Advocacy in Action: Cancer Support Community Public Policy Initiatives
In this Advocacy in Action episode, Linda House (Executive Vice-President of External Affairs, Cancer Support Community) talks about the three pillars of focus for the Cancer Support Community.
To view all of the videos in this series, click here.
Public policies may encourage or prohibit further advancements or access to the latest care and treatments. Although cancer survivors are more likely to return to their jobs and families, they are forever changed by their experiences. Legislators may have a different view the role of public policies after they consider the issues of cancer survivors and their families.
There are many legislative and regulatory issues that surround Public Policy Advocacy and impact oncology care and that influence clinical advancements and access to treatment.
Some of the issues in cancer public policy include:
• Drug Shortages
• Advanced Cancer Care Planning
• NIH/NCI/FDA Appropriations
• Access to Care
• Value in Cancer Care
• Drug Safety
• Reimbursement
• Medicare
Joining Vital Options CEO, Selma Schimmel, as co-moderators for Public Policy Advocacy in Cancer Care will be Nancy Davenport-Ennis, Patient Advocate Foundation; Linda House, Cancer Support Community; Ted Okon, Community Oncology Alliance; Charles Penley, MD, ASCO Government Relations Committee; and Scott Williams, Men’s Health Network.
Advocacy in Action at the American Society of Clinical Oncology (ASCO) Annual Meeting 2012 was made possible, in part, by:
